{"acute pulmonary oedema": 19.66, "adverse event": 4.77, "airway complication of anaesthesia": 408.58, "anaphylactic reaction": 64.38, "anaphylactic shock": 164.92, "anaphylactoid reaction": 86.94, "angioedema": 3.97, "apnoea": 10.74, "arteriospasm coronary": 75.42, "atrioventricular block complete": 20.87, "blood pressure decreased": 25.52, "bradycardia": 72.57, "bronchospasm": 103.04, "cardiac arrest": 34.51, "cardio-respiratory arrest": 9.34, "circulatory collapse": 5.95, "cyanosis": 4.7, "depressed level of consciousness": 3.96, "drug hypersensitivity": 7.14, "endotracheal intubation": 46.48, "erythema": 5.28, "eyelid oedema": 13.12, "face oedema": 3.45, "flushing": 3.05, "heart rate decreased": 5.51, "hypersensitivity": 3.94, "hypertensive crisis": 5.12, "hypotension": 10.42, "hypoventilation": 93.19, "hypoxia": 14.39, "incorrect dose administered": 5.49, "kounis syndrome": 392.08, "laryngeal oedema": 8.32, "laryngospasm": 164.87, "muscle rigidity": 9.43, "neuromuscular block prolonged": 1401.17, "overdose": 4.17, "oxygen saturation decreased": 16.92, "paralysis": 3.74, "product administered to patient of inappropriate age": 15.31, "product use issue": 2.96, "pulmonary oedema": 9.66, "pulseless electrical activity": 75.92, "recurrence of neuromuscular blockade": 11346.7, "respiratory arrest": 34.6, "respiratory depression": 15.62, "respiratory failure": 4.04, "shock": 8.33, "supraventricular tachycardia": 10.91, "tachycardia": 2.52, "therapeutic product effect incomplete": 3.09, "type i hypersensitivity": 46.9, "underdose": 7.79, "urticaria": 4.09, "ventricular fibrillation": 22.11, "ventricular tachycardia": 10.53, "wheezing": 5.2}